AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Sign up Log in

Emergent BioSolutions Inc. Director's Dealing 2024

Nov 21, 2024

32870_dirs_2024-11-21_eb6af28b-811f-439a-82b8-80cebe619ea1.zip

Director's Dealing

Opens in your device viewer

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: Emergent BioSolutions Inc. (EBS)
CIK: 0001367644
Period of Report: 2024-11-18

Reporting Person: Lowry Simon C (SVP, R&D, CMO)

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	0	Direct